Protective action of hepatocyte growth factor for acute liver injurry caused by D-Galactosamine in transgenic mice

Hepatology

Volumn 26, Issue 5, 1997, Pages 1241-1249

  Okano, Jun Ichi ^a   Shiota, Goshi ^a   Kawasaki, Hironaka ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; CYCLINE; GALACTOSAMINE; PROSTAGLANDIN E2; SCATTER FACTOR;

ADOLESCENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; LIVER INJURY; LIVER PROTECTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SURVIVAL; TRANSGENIC MOUSE;

EID: 0030715686     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510260523     Document Type: Article

References (54)

1. Nakamura T, Nawa K, Ichihara A. Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem Biophys Res Commun 1984;122:1450-1459.
2. Nakamura T, Nawa K, Ichihara A, Kaise N, Nishino T. Purification and subunit structure of hepatocyte growth factor from rat platelets. FEBS Lett 1987;224:311-316.
3. 2-terminal amino acid sequence of rabbit hepatopoietin A: a heparin-binding polypeptide growth factor for hepatocytes. Biochem Biophys Res Commun 1989; 163:1370-1376.
4. Gohda E, Tsubouchi H, Nakayama H, Hirano H, Sakiyama O, Takahashi K, Miyazaki H, et al. Purification and partial characterization of hepatocyte growth factor from plasma of a patient with hepatic failure. J Clin Invest 1988;81:414-419.
5. Rubin JS, Chan AML, Bottaro DP, Burgess WH, Taylor WG, Cech AC, Hirschfield DW, et al. A broad-spectrum human lung fibroblast-derived mitogen is a variant of hepatocyte growth factor. Proc Natl Acad Sci U S A 1991;88:415-419.
6. Montesano R, Matsumoto K, Nakamura T, Orci L. Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor. Cell 1991;67:901-908.
7. Weidner KM, Arakaki N, Hartmann G, Vanderhove J, Weingart S, Rieder H, Fonatsch C, et al. Evidence for the identity of human scatter factor and human hepatocyte growth factor. Proc Natl Acad Sci U S A 1991;88:7001-7005.
8. Boros P, Miller CM. Hepatocyte growth factor: a multifunctional cytokine. Lancet 1995;345:293-295.
9. Takehara T, Nakamura T. Protective effect of hepatocyte growth factor on in vitro hepatitis in primary cultured hepatocytes. Biomed Res 1991; 12:335-338.
10. Ishiki Y, Ohnishi H, Muto Y, Matsumoto K, Nakamura T. Direct evidence that hepatocyte growth factor is a hepatotropic factor for liver regeneration and has a potent antihepatitis effect in vivo. HEPATOLOGY 1992;16:1227-1235.
11. Roos F, Terrell TG, Godowski PJ, Chamow SM, Schwall RH. Reduction of α-naphtylisothiocyanate-induced hepatotoxicity by recombinant human hepatocyte growth factor. Endocrinology 1992;131:2540-2544.
12. Morita M, Watanabe Y, Akaike T. Protective effect of hepatocyte growth factor on interferon-gamma-induced cytotoxicity in mouse hepatocytes. HEPATOLOGY 1995;21:1585-1593.
13. 2 and some drugs on an acute galactosamine induced liver damage in rat. Folia Histochem Cytochem 1980;9:311-318.
14. Stachura J, Tarnawski A, Ivey KJ, Mach T, Bogdal J, Szczudrawa J, Klimczyk B. Prostaglandin protection of carbon tetrachloride-induced liver cell necrosis in the rat. Gastroenterology 1981;81:211-217.
15. 2 on the liver and kidney. Prostaglandins 1981; 21:97-102.
16. 2 in carbon tetrachloride-induced acute hepatic injury in the rat. Prostaglandins 1986;32:439-455.
17. Araki H, Lefer AM. Cytoprotective actions of prostacyclin during hypoxia in the isolated perfused cat liver. Am J Physiol 1980;238:176-180.
18. 1 in an experimental massive hepatic cell necrosis model. HEPATOLOGY 1987; 7:1184-1188.
19. 2) and a prostaglandin analogue BW 245C on galactosamine-induced hepatic necrosis. J Hepatol 1986;2:53-64.
20. Alp MH, Hickman R. The effect of prostaglandins, branched-chain amino acids and other drags on the outcome of experimental acute porcine hepatic failure. J Hepatol 1987;4:99-107.
21. 1 on T-cell mediated cytotoxicity against isolated mouse liver cells. Gastroenterology 1988;94:24-30.
22. 2: favorable effects on rat liver injury. Gastroenterology 1992;102: 572-576.
23. Hori T, Shibamoto S, Hayakawa M, Takeuchi K, Oku N, Miyazawa K, Kitamura N, et al. Stimulation of prostaglandin production by hepatocyte growth factor in human carcinoma cells. FEBS Lett 1993;334:331-334.
24. Adachi T, Nakashima S, Saji S, Nakamura T, Nozawa Y. Roles of prostaglandin production and mitogen-activated protein kinase activation in hepatocyte growth factor-mediated rat hepatocyte proliferation. HEPATOLOGY 1995;21:1668-1674.
25. Shiota G, Rhoads DR, Wang TC, Nakamura T, Schmidt EV. Hepatocyte growth factor inhibits growth of hepatocellular carcinoma cells. Proc Natl Acad Sci U S A 1992;89:373-377.
26. Shiota G, Wang TC, Nakamura T, Schmidt EV. Hepatocyte growth factor in transgenic mice: effects on hepatocyte growth, liver regeneration and gene expression. HEPATOLOGY 1994;19:962-972.
27. Fujiwara K, Nagoshi S, Ohno A, Hirata K, Ohta Y, Mochida S, Tomiya T, et al. Stimulation of liver growth by exogenous human hepatocyte growth factor in normal and partially hepatectomized rats. HEPATOLOGY 1993;18:1443-1449.
28. Roos F, Ryan AM, Chamow SM, Bennett GL, Schwall RH. Induction of liver growth in normal mice by infusion of hepatocyte growth factor/ scatter factor. Am J Physiol 1995;268:G380-G386.
29. Taketo M, Schroeder AC, Mobraaten LE, Gunning KB, Hanten G, Fox RR, Roderick TH, et al. FVB/N: an inbred mouse strain preferable for transgenic analyses. Proc Natl Acad Sci U S A 1991;88:2065-2069.
30. Sambrook J, Fritisch EF, Maniatis T. Molecular Cloning: A laboratory manual. New York: Cold Spring Harbor Press, 1989.
31. Ishida M, Gomyo Y, Ohfuji S, Ikeda M, Ito H, Kawasaki H. Evidence that expression of a mutated p53 gene attenuates apoptotic cell death in human gastric intestinal-type carcinoma in vitro. Jap J Cancer Res 1997;88:468-475.
32. Nakamura T, Nishizawa T, Hagiya M, Seki T, Shimonishi M, Sugiyama A, Tashiro K, et al. Molecular cloning and expression of human hepatocyte growth factor. Nature 1989;342:440-443.
33. Yamada A, Matsumoto K, Iwanari H, Sekiguchi K, Kawata S, Matsuzawa Y, Nakamura T. Rapid and sensitive enzyme-linked immunosorbent assay for measurement of HGF in rat and human tissues. Biomed Res 1995;16:105-114.
34. Kaplan EL, Meier P. Nonparametric estimation for incomplete observation. J Am Stat Assoc 1959;53:457-481.
35. Matsumoto K, Nakamura T. Roles of HGF as a pleiotropic factor in organ regeneration. In: Goldberg ID, Rosen EM, eds. Hepatocyte Growth Factor-Scatter Factor (HGF-SF) and C-Met Receptor. Basel: Birkhäuser Verlag, 1993:225-249.
36. Nakamura T. Structure and function of hepatocyte growth factor. Progr Growth Factor Res 1991;3:67-85.
37. Gherardi E, Stoker M. Hepatocytes and scatter factor. Scientific correspondence. Nature 1990;346:228.
38. Higashio K, Shima N, Goto M, Itagaki Y, Nagao M, Yasuda H, Morinaga T. Identity of a tumor cytotoxic factor from human fibroblasts and hepatocyte growth factor. Biochem Biophys Res Commun 1991;170: 397-404.
39. Tajima H, Matsumoto K, Nakamura T. Hepatocyte growth factor has anti-tumor activity in various tumor cell lines. FEBS 1991;291:229-232.
40. Mizuno K, Nakamura T. Molecular characteristics of HGF and the gene, and its biochemical aspects. In: Goldberg ID, Rosen EM, eds. Hepatocyte Growth Factor-Scatter Factor (HGF-SF) and C-Met Receptor. Basel: Birkhäuser Verlag, 1993:1-29.
41. Lee JB, Katayama S. Prostaglandins, thromboxanes, and leukotrienes. In: Wilson JD, Foster DW, eds. Textbook of Endocrinology. 7th ed. Philadelphia: Saunders, 1985:1345-1362.
42. Hashimoto N, Watanabe T, Shiratori Y, Ikeda Y, Kato H, Han K, Yamada H, et al. Prostanoid secretion by rat hepatic sinusoidal endothelial cells and its regulation by exogenous adenosine triphosphate. HEPATOLOGY 1995;21:1713-1718.
43. Sinclair SB, Greig PD, Blendis LM, Abecassis M, Roberts EA, Phillips M, Cameron R, et al. Biochemical and clinical response of fulminant viral hepatitis to administration of prostaglandin E. J Clin Invest 1989; 84:1063-1069.
44. 2 regulates macrophage-derived tumor necrosis factor gene expression. J Biol Chem 1988;263:5380-5384.
45. 2 and dexamethasone. J Hepatol 1988;7:352-361.
46. Keppler D, Lesh R, Reutter W, Decker K. Experimental hepatitis by D-galactosamine. Exp Mol Pathol 1968;9:279-290.
47. Decker K, Keppler D. Galactosamine-induced liver injury. In: Popper H, Schaffner F, eds. Progress in Liver Diseases. New York: Grune & Stratton, 1972;4:183-199.
48. Jonker AM, Dijkhuis FWJ, Kroese FGM, Hardonk MJ, Grond J. Immunopathology of acute galactosamine hepatitis in rats. HEPATOLOGY 1990; 11:622-627.
49. EL-Mofty SK, Scrutton MC, Serroni A, Nicolini C, Farber JL. Early, reversible plasma membrane injury in galactosamine-induced liver cell death. Am J Pathol 1975;79:579-595.
50. 1 to rat hepatocytes. Biochem Biophys Res Commun 1992;184:654-660.
51. Matsumoto K, Okazaki H, Nakamura T. Novel function of prostaglandins as inducers of gene expression of HGF and putative mediators of tissue regeneration. J Biochem 1995;117:458-464.
52. Birmalin M, Decker K. Synthesis of prostanoids and cyclic nucleotides by phagocytosing rat Kupffer cells. Eur J Biochem 1984;142:219-225.
53. Kawada N, Mizoguchi Y, Kobayashi K, Monna T, Morisawa S, Ueda N, Omoto Y, et al. Possible induction of fatty acid cyclooxygenase in lipopolysaccharide-stimulated rat Kupffer cells. Gastroenterology 1992; 103:1026-1033.
54. Noji S, Tashiro K, Koyama E, Nohno T, Ohyama K, Taniguchi S, Nakamura T. Expression of hepatocyte growth factor gene in endothelial and Kupffer cells of damaged rat livers, as revealed by in situ hybridization. Biochem Biophys Res Commun 1990;173:42-47.